Inventor · disambiguated record
Dan V. Mourich
Also filed as: MOURICH DAN V · MOURICH DAN VINCENT
12 granted patents·11 pending applications·147 citations·filing 2004–2024
90Inventor score
Files withMOURICH DAN V9SAREPTA THERAPEUTICS INC8AVI BIOPHARMA INC2HINRICHS DAVID J1SCHNELL FREDERICK J1
Top patents by PatentIndex Score
23 records- 0195US8501704B2Immunosuppression compound and treatment methodMOURICH DAN V·Filed 2008·Granted Aug 6, 2013·38 cites·16 claims
- 0295US8415313B2Antisense oligomers and methods for inducing immune tolerance and immunosuppressionMOURICH DAN V·Filed 2006·Granted Apr 9, 2013·25 cites·14 claims
- 0394US8008469B2Antisense compound for inducing immunological toleranceAVI BIOPHARMA INC·Filed 2007·Granted Aug 30, 2011·20 cites·10 claims
- 0492US7989608B2Immunomodulatory agents and methods of useAVI BIOPHARMA INC·Filed 2008·Granted Aug 2, 2011·19 cites·22 claims
- 0591US8592386B2Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitisMOURICH DAN V·Filed 2009·Granted Nov 26, 2013·36 cites·14 claims
- 0679US9238042B2Antisense modulation of interleukins 17 and 23 signalingSCHNELL FREDERICK J·Filed 2011·Granted Jan 19, 2016·8 cites·24 claims
- 0776US2024415857A1Antisense-induced exon exclusion in type vii collagenSAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0870US11911403B2Antisense-induced exon exclusion in type VII collagenSAREPTA THERAPEUTICS INC·Filed 2020·Granted Feb 27, 2024·0 cites·8 claims
- 0970US11629190B2Canine antibody therapeutic for treating cancerUNIV OREGON STATE·Filed 2020·Granted Apr 18, 2023·1 cites·20 claims
- 1065US9487786B2Immunosuppression compound and treatment methodSAREPTA THERAPEUTICS INC·Filed 2014·Granted Nov 8, 2016·0 cites·21 claims
- 1164US2005222068A1Method and antisense composition for selective inhibition of HIV infection in hematopoietic cellsMOURICH DAN V·Filed 2004·Application pending·0 cites
- 1260US8933216B2Immunosuppression compound and treatment methodSAREPTA THERAPEUTICS INC·Filed 2013·Granted Jan 13, 2015·0 cites·13 claims
- 1360US2007037764A1Method and antisense composition for selective inhibition of HIV infection in hematopoietic cellsMOURICH DAN V·Filed 2006·Application pending·0 cites
- 1459US2021283170A1Methods and compounds for treatment of lymphocyte-related diseases and conditionsSAREPTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1558US10849917B2Antisense-induced exon exclusion in type VII collagenSAREPTA THERAPEUTICS INC·Filed 2016·Granted Dec 1, 2020·0 cites·13 claims
- 1657US2005234002A1Antisense oligomers and methods for inducing immune tolerance and immunosuppressionMOURICH DAN V·Filed 2005·Application pending·0 cites
- 1754US2012027791A1Antisense compound for inducing immunological toleranceMOURICH DAN V·Filed 2011·Application pending·0 cites
- 1853US2006240032A1Immunomodulating compositions and methods for use in the treatment of human autoimmune diseasesHINRICHS DAVID J·Filed 2006·Application pending·0 cites
- 1953US2014287983A1Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitisSAREPTA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2052US2005203041A1Antisense compound and method for selectively killing activated T cellsFiled 2004·Application pending·0 cites
- 2147US2007111962A1Immunosuppression compound and treatment methodMOURICH DAN V·Filed 2006·Application pending·0 cites
- 2246US2011318382A1Immunomodulatory agents and methods of useMOURICH DAN V·Filed 2011·Application pending·0 cites
- 2342US11020417B2Methods and compounds for treatment of lymphocyte-related diseases and conditionsSAREPTA THERAPEUTICS INC·Filed 2016·Granted Jun 1, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Dan V. Mourich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →